Form 4 for NVCR NovoCure Ltd
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-10 · accession 0001645113-22-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-16 | 2022-06-10 | NVCR | HILLEMAN JERYL L | Dir | S - Sale | $69.61 | -407 | 2,537 | -14% | -$28.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-06-10 | S | D | 407 | $69.61 | 2,537 | D | — | — | (F1) Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman. |